Intra- and extracellular distribution and immunochemical characterization of hepatitis B virus nucleocapsid proteins produced by a human hepatoma cell line transfected with cloned viral DNA
- PMID: 2535906
- DOI: 10.1016/0042-6822(89)90401-7
Intra- and extracellular distribution and immunochemical characterization of hepatitis B virus nucleocapsid proteins produced by a human hepatoma cell line transfected with cloned viral DNA
Abstract
Hepatitis B virus (HBV)-related antigens produced by the human hepatoma cell line (HB611 cell), which had been transfected with a cloned HBV DNA and established as a stable producer of HBV (T. Tsurimoto, A. Fujiyama, and K. Matsubara, 1987, Proc. Natl. Acad. Sci. USA 84, 444-448), were investigated immunochemically and morphologically. All HBV-related antigens, HBV surface (HBsAg), e (HBeAg), and core (HBcAg), were semiquantitatively examined by the respective reversed passive hemagglutination assay (RPHA). RPHAs for HBcAg and for HBeAg were characterized as reacting only to the core particles and to the free form of nucleocapsid proteins, respectively. The amounts of HBsAg and nucleocapsid protein in culture medium were roughly related to the number of viable cells. The amount of core particles was, instead, proportional to the number of dead cells. Relative amounts of HBsAg, core particles, and nucleocapsid proteins in culture medium, cell surface, and cell lysate were determined and it was found that HBsAg and nucleocapsid proteins were effectively secreted into culture medium but core particles were not. Molecular species of nucleocapsid proteins were identified to be p17 and p18 (HBeAg polypeptides) in the culture medium and HBeAg polypeptides and p21.5 (HBcAg polypeptide) in the cytosol fraction. The p21.5 was preferentially found in the nuclear fraction.
Similar articles
-
Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro.Lab Invest. 1988 Aug;59(2):173-80. Lab Invest. 1988. PMID: 2841537
-
Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.World J Gastroenterol. 2016 Mar 28;22(12):3404-11. doi: 10.3748/wjg.v22.i12.3404. World J Gastroenterol. 2016. PMID: 27022222 Free PMC article.
-
[An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].Zhonghua Gan Zang Bing Za Zhi. 2002 Aug;10(4):275-8. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12223138 Chinese.
-
Intracellular Trafficking of HBV Particles.Cells. 2020 Sep 2;9(9):2023. doi: 10.3390/cells9092023. Cells. 2020. PMID: 32887393 Free PMC article. Review.
-
[Recent advances in understanding and diagnosing hepatitis B virus infection].Virologie (Montrouge). 2019 Feb 1;23(1):23-34. doi: 10.1684/vir.2019.0760. Virologie (Montrouge). 2019. PMID: 31131827 Review. French.
Cited by
-
Pathomorphological Characteristics and Pathogenesis of Viral Hepatitis.Pathol Oncol Res. 1996;2(3):117-131. doi: 10.1007/BF02903516. Pathol Oncol Res. 1996. PMID: 11173596
-
Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.Arch Virol. 1991;118(1-2):11-27. doi: 10.1007/BF01311300. Arch Virol. 1991. PMID: 1828660
-
Nucleolar localization of human hepatitis B virus capsid protein.J Virol. 2004 Dec;78(24):13653-68. doi: 10.1128/JVI.78.24.13653-13668.2004. J Virol. 2004. PMID: 15564475 Free PMC article.